Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Our third video from the Targeted Therapies in Lung Cancer Patient Forum, filmed in Aurora Colorado on August 20, 2016, is the second part of the forum breakout session for ALK + patients and caregivers, featuring Dr. Shirish Gadgeel and patient moderator Linnea Olson.
On August 20, 2016, in collaboration with the University of Colorado Cancer Center, GRACE presented the Targeted Therapies in Lung Cancer Patient Forum in Aurora Colorado. We are happy to share the videos from this live and webcast forum. Our second video is the first part of the forum breakout session for ALK + patients and caregivers, featuring Dr. Shirish Gadgeel and patient moderator Linnea Olson.
On August 20, 2016, in collaboration with the University of Colorado Cancer Center, GRACE presented the Targeted Therapies in Lung Cancer Patient Forum in Aurora Colorado. We are happy to share the videos from this live and webcast forum. Our first video welcomes all to the event, and it was our extreme pleasure to have Chris Draft and Dr. Ross Camidge join us to start the day! This is followed by keynote topic "Does NED matter? Using “curative” surgery or radiation techniques to treat "incurable" advanced lung cancer," with Dr. Rob Meguid, and a panel discussion featuring Dr. Meguid, Dr. Chad Rusthoven, Dr. Ross Camidge, and chaired by Dr. H. Jack West.
For our third video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD, Medical Oncologist, Thoracic Oncology Program, Hospital General Universitario, Gregorio Marraron, Madrid, Spain joined GRACE to discuss how NSCLC subtype (histology) can alter chemotherapy recommendations in advanced NSCLC.
For our second video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD, Medical Oncologist, Thoracic Oncology Program, Hospital General Universitario, Gregorio Marraron, Madrid, Spain joined GRACE to discuss what is the value of chemotherapy in advanced/metastatic NSCLC.
In this giving season, we thank you for your generosity. Your donation helps thousands of people living with cancer become educated about their...
Join GRACE for this annual Live Online event featuring the top oncologists in their field discussing the most current Lung Cancer Updates and...
Join GRACE for this annual Live Online event featuring the top oncologists in their field discussing the most current Lung Cancer Updates and...
Have you received a diagnosis of multiple myeloma? GRACE is excited to have again partnered with Clinical Care Options to develop an Interactive...
Just found this site and am looking for some information about lung IMA. I was diagnosed May, 2020 and had left lower lung lobectomy. The tumor was...
Hello. I am here to see if anyone can share symptoms of pancoast. And if you can, please, answer some questions. My story: About a month-ish ago, I...
I was diagnosed from a lymph node biopsy in early February of this year. After many tests I've have NSCLC stage IV with brain metastases. They just...
Afatnib v. Tagrisso for Stage 2B rare EGFR mutation, G 719X Adenocarcinoma lung cancer Diagnosed with Lung Cancer in January, 2021. Had been a smoker...
This is regarding french kissing for about 5 min. The woman had radiation for cervical cancer at 20, and a hysterectomy for reoccurance, recently at...
Transcript
I think there are several goals when treating a patient with advanced non-small cell lung cancer. For one I think we want to extend life, two is I think we want to palliate symptoms, and three is I think we want to improve quality of life. So all three of those goals are achievable, I think, with the therapies that we have right now.
Dr. David Harpole, Duke University Medical Center, defines the concept of mediastinal node sterilization and its use after neoadjuvant therapy.
Dr. David Harpole, Duke University Medical Center, describes the sleeve resection and how it can help selected patients with large tumors retain lung function.
Dr. David Harpole, Duke University Medical Center, describes the mediastinoscopy and its use in lung cancer staging.
Dr. David Harpole, Duke University Medical Center, details the methods thoracic surgeons use to assess a patient's fitness for surgery.
Dr. David Harpole, Duke University Medical Center, describes how he assists patients with the surgical decision-making process.
Dr. Nasser Hanna, Indiana University Health, addresses the issue of prophylactic cranial irradiation (PCI) in locally advanced NSCLC.
Dr. Nasser Hanna, Indiana University Health, discusses the possible role of immunotherapy in locally advanced NSCLC.
Dr. Nasser Hanna, Indiana University Health, lists chemo regiments appropriate for use with radiation in locally advanced NSCLC.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.